title: Safe and well-tolerated treatment with ivabradine in systemic sclerosis affected by pulmonary hypertension.
authors.forename: Michele
authors.initials: M
authors.lastname: Correale
authors.forename: Deodata
authors.initials: D
authors.lastname: Montrone
authors.forename: Matteo Di
authors.initials: MD
authors.lastname: Biase
authors.forename: Natale Daniele
authors.initials: ND
authors.lastname: Brunetti
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001552:Benzazepines / Q000009:adverse effects / Q000627:therapeutic use*; D006328:Cardiac Catheterization; D004359:Drug Therapy, Combination; D015150:Echocardiography, Doppler; D005080:Exercise Test; D017079:Exercise Tolerance / Q000187:drug effects; D065627:Familial Primary Pulmonary Hypertension; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D000077550:Ivabradine; D008875:Middle Aged; D011651:Pulmonary Artery / Q000187:drug effects / Q000503:physiopathology; D011669:Pulmonary Wedge Pressure / Q000187:drug effects; D012595:Scleroderma, Systemic / Q000150:complications*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D001552:Benzazepines; D000077550:Ivabradine